R+D

Collaborative projects

ACINETOCLINIC is a project focused on completing the transition to human clinical development stage (Phase I in healthy volunteers) of the first universal vaccine against infections caused by the antibiotic-resistant bacterium Acinetobacter baumannii. ACINETOCLINIC is funded by the 2016 RETOS-COLABORACIÓN program of the Ministry of Economy, Industry and Competitiveness and co-financed by the FEDER

PREVINFECTRA Is a project focused on prevention, diagnosis and treatment of hospital-acquired infections, through the research and the development of new compounds that act by the selective elimination of natural antibodies related to greater suceptibility to infectious diseases. PREVINFECTRA is funded by 2016 Nucli d’R+D Empresarial, a program of ACCIO (Catalonian Agency for the competitiveness) and co-financed by the FEDER.